Report Overview
Report Overview
The drug of abuse test is an immunoassay based on the principle of competitive binding. North America will dominate the drug of abuse testing market in 2022 owing to high R&D investment, presence of global players, increasing adoption of technologically advanced solutions, and efforts of major companies. In North America, the U.S. accounted for the major share accounting for 90% owing to the rise in the use of illicit drugs and the resulting increase in health problems. Rising monitoring of illicit drug consumption in the workplace and rise in drug trafficking are other factors contributing to the market growth.
The global Drug of Abuse (DOA) Testing market size was estimated at USD 6939.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Drug of Abuse (DOA) Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Drug of Abuse (DOA) Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Drug of Abuse (DOA) Testing market.
Global Drug of Abuse (DOA) Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Siemens
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Psychemedics
Market Segmentation (by Type)
Urine
Saliva
Hair
Others
Market Segmentation (by Application)
Hospitals
Laboratories
Workplace
At-Home
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Drug of Abuse (DOA) Testing Market
Overview of the regional outlook of the Drug of Abuse (DOA) Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug of Abuse (DOA) Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Drug of Abuse (DOA) Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Drug of Abuse (DOA) Testing
- 1.2 Key Market Segments
- 1.2.1 Drug of Abuse (DOA) Testing Segment by Type
- 1.2.2 Drug of Abuse (DOA) Testing Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Drug of Abuse (DOA) Testing Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Drug of Abuse (DOA) Testing Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global Drug of Abuse (DOA) Testing Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 2.1 Global Market Overview
- 3 Drug of Abuse (DOA) Testing Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Drug of Abuse (DOA) Testing Product Life Cycle
- 3.3 Global Drug of Abuse (DOA) Testing Sales by Manufacturers (2020-2025)
- 3.4 Global Drug of Abuse (DOA) Testing Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Drug of Abuse (DOA) Testing Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Drug of Abuse (DOA) Testing Market Competitive Situation and Trends
- 3.8.1 Drug of Abuse (DOA) Testing Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Drug of Abuse (DOA) Testing Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Drug of Abuse (DOA) Testing Industry Chain Analysis
- 4.1 Drug of Abuse (DOA) Testing Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Drug of Abuse (DOA) Testing Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Drug of Abuse (DOA) Testing Market Porters Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Drug of Abuse (DOA) Testing Market
- 5.7 ESG Ratings of Leading Companies
- 6 Drug of Abuse (DOA) Testing Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Drug of Abuse (DOA) Testing Sales Market Share by Type (2020-2025)
- 6.3 Global Drug of Abuse (DOA) Testing Market Size by Type (2020-2025)
- 6.4 Global Drug of Abuse (DOA) Testing Price by Type (2020-2025)
- 7 Drug of Abuse (DOA) Testing Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Drug of Abuse (DOA) Testing Market Sales by Application (2020-2025)
- 7.3 Global Drug of Abuse (DOA) Testing Market Size (M USD) by Application (2020-2025)
- 7.4 Global Drug of Abuse (DOA) Testing Sales Growth Rate by Application (2020-2025)
- 8 Drug of Abuse (DOA) Testing Market Sales by Region
- 8.1 Global Drug of Abuse (DOA) Testing Sales by Region
- 8.1.1 Global Drug of Abuse (DOA) Testing Sales by Region
- 8.1.2 Global Drug of Abuse (DOA) Testing Sales Market Share by Region
- 8.2 Global Drug of Abuse (DOA) Testing Market Size by Region
- 8.2.1 Global Drug of Abuse (DOA) Testing Market Size by Region
- 8.2.2 Global Drug of Abuse (DOA) Testing Market Size by Region
- 8.3 North America
- 8.3.1 North America Drug of Abuse (DOA) Testing Sales by Country
- 8.3.2 North America Drug of Abuse (DOA) Testing Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Drug of Abuse (DOA) Testing Sales by Country
- 8.4.2 Europe Drug of Abuse (DOA) Testing Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Drug of Abuse (DOA) Testing Sales by Region
- 8.5.2 Asia Pacific Drug of Abuse (DOA) Testing Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Drug of Abuse (DOA) Testing Sales by Country
- 8.6.2 South America Drug of Abuse (DOA) Testing Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Drug of Abuse (DOA) Testing Sales by Region
- 8.7.2 Middle East and Africa Drug of Abuse (DOA) Testing Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 8.1 Global Drug of Abuse (DOA) Testing Sales by Region
- 9 Drug of Abuse (DOA) Testing Market Production by Region
- 9.1 Global Production of Drug of Abuse (DOA) Testing by Region(2020-2025)
- 9.2 Global Drug of Abuse (DOA) Testing Revenue Market Share by Region (2020-2025)
- 9.3 Global Drug of Abuse (DOA) Testing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Drug of Abuse (DOA) Testing Production
- 9.4.1 North America Drug of Abuse (DOA) Testing Production Growth Rate (2020-2025)
- 9.4.2 North America Drug of Abuse (DOA) Testing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Drug of Abuse (DOA) Testing Production
- 9.5.1 Europe Drug of Abuse (DOA) Testing Production Growth Rate (2020-2025)
- 9.5.2 Europe Drug of Abuse (DOA) Testing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Drug of Abuse (DOA) Testing Production (2020-2025)
- 9.6.1 Japan Drug of Abuse (DOA) Testing Production Growth Rate (2020-2025)
- 9.6.2 Japan Drug of Abuse (DOA) Testing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Drug of Abuse (DOA) Testing Production (2020-2025)
- 9.7.1 China Drug of Abuse (DOA) Testing Production Growth Rate (2020-2025)
- 9.7.2 China Drug of Abuse (DOA) Testing Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Siemens
- 10.1.1 Siemens Basic Information
- 10.1.2 Siemens Drug of Abuse (DOA) Testing Product Overview
- 10.1.3 Siemens Drug of Abuse (DOA) Testing Product Market Performance
- 10.1.4 Siemens Business Overview
- 10.1.5 Siemens SWOT Analysis
- 10.1.6 Siemens Recent Developments
- 10.2 Merck
- 10.2.1 Merck Basic Information
- 10.2.2 Merck Drug of Abuse (DOA) Testing Product Overview
- 10.2.3 Merck Drug of Abuse (DOA) Testing Product Market Performance
- 10.2.4 Merck Business Overview
- 10.2.5 Merck SWOT Analysis
- 10.2.6 Merck Recent Developments
- 10.3 Roche
- 10.3.1 Roche Basic Information
- 10.3.2 Roche Drug of Abuse (DOA) Testing Product Overview
- 10.3.3 Roche Drug of Abuse (DOA) Testing Product Market Performance
- 10.3.4 Roche Business Overview
- 10.3.5 Roche SWOT Analysis
- 10.3.6 Roche Recent Developments
- 10.4 Thermo Fisher Scientific
- 10.4.1 Thermo Fisher Scientific Basic Information
- 10.4.2 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Product Overview
- 10.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Product Market Performance
- 10.4.4 Thermo Fisher Scientific Business Overview
- 10.4.5 Thermo Fisher Scientific Recent Developments
- 10.5 Bio-Rad
- 10.5.1 Bio-Rad Basic Information
- 10.5.2 Bio-Rad Drug of Abuse (DOA) Testing Product Overview
- 10.5.3 Bio-Rad Drug of Abuse (DOA) Testing Product Market Performance
- 10.5.4 Bio-Rad Business Overview
- 10.5.5 Bio-Rad Recent Developments
- 10.6 Abbott
- 10.6.1 Abbott Basic Information
- 10.6.2 Abbott Drug of Abuse (DOA) Testing Product Overview
- 10.6.3 Abbott Drug of Abuse (DOA) Testing Product Market Performance
- 10.6.4 Abbott Business Overview
- 10.6.5 Abbott Recent Developments
- 10.7 Quest Diagnostics
- 10.7.1 Quest Diagnostics Basic Information
- 10.7.2 Quest Diagnostics Drug of Abuse (DOA) Testing Product Overview
- 10.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Product Market Performance
- 10.7.4 Quest Diagnostics Business Overview
- 10.7.5 Quest Diagnostics Recent Developments
- 10.8 Psychemedics
- 10.8.1 Psychemedics Basic Information
- 10.8.2 Psychemedics Drug of Abuse (DOA) Testing Product Overview
- 10.8.3 Psychemedics Drug of Abuse (DOA) Testing Product Market Performance
- 10.8.4 Psychemedics Business Overview
- 10.8.5 Psychemedics Recent Developments
- 10.1 Siemens
- 11 Drug of Abuse (DOA) Testing Market Forecast by Region
- 11.1 Global Drug of Abuse (DOA) Testing Market Size Forecast
- 11.2 Global Drug of Abuse (DOA) Testing Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Drug of Abuse (DOA) Testing Market Size Forecast by Country
- 11.2.3 Asia Pacific Drug of Abuse (DOA) Testing Market Size Forecast by Region
- 11.2.4 South America Drug of Abuse (DOA) Testing Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Drug of Abuse (DOA) Testing by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global Drug of Abuse (DOA) Testing Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of Drug of Abuse (DOA) Testing by Type (2026-2035)
- 12.1.2 Global Drug of Abuse (DOA) Testing Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of Drug of Abuse (DOA) Testing by Type (2026-2035)
- 12.2 Global Drug of Abuse (DOA) Testing Market Forecast by Application (2026-2035)
- 12.2.1 Global Drug of Abuse (DOA) Testing Sales (K Units) Forecast by Application
- 12.2.2 Global Drug of Abuse (DOA) Testing Market Size (M USD) Forecast by Application (2026-2035)
- 12.1 Global Drug of Abuse (DOA) Testing Market Forecast by Type (2026-2035)
- 13 Conclusion and Key Findings